Quarterly profit was $31 million at Waystar, with a 10% net income margin.

Waystar reported Q3 2026 revenue of $325.6M, up 21% YoY, with net income of $31M and a 10% margin. CEO Matt Hawkins highlighted strong demand and AI adoption. Full-year guidance includes revenue between $1.277B and $1.287B. The company will discuss results on a conference call.

Original reporting
Published Nov 2, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$WAY
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

High
01

Why it matters

The earnings release provides fresh data on revenue growth, profitability, and FY outlook.

02

Market read

First‑time earnings disclosure with raised guidance; likely catalyst for short‑term price movement.

03

What to watch

Potential headwinds from payer consolidation and AI implementation costs.

Relevance 8/10Novelty 9/10Timing: after‑hours today

Background

Waystar is a provider of revenue‑cycle management software for healthcare providers.

Market effects

Positive for healthcare revenue‑cycle software sector, may boost peers.

U.S. tech/healthcare markets could see modest lift.

Limited to U.S. investors; no broader macro effect.

Counterpoint

If guidance falls short of analyst expectations, the stock could face a sell‑off.

Key entities

  • Matt Hawkins

    CEO of Waystar, quoted in the release.

Related articles

$WAYHighAI 8/10

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.

$WAYHighAI 8/10

Waystar shares tumble 7% on weak fiscal 2026 guidance

Waystar Holding Corp (WAY) reported Q3 earnings of $0.44 per share, beating estimates, with revenue up 21% YoY to $325.6M. However, shares fell 7.3% on weak fiscal 2026 guidance, with projected EPS of $1.63-$1.71 and revenue of $1.277B-$1.287B, both below consensus. The company reported 10% net income margin and 43% adjusted EBITDA margin.